Atlas search results
258 search results with ""
No results found.
- Surgical aortic valve interventions (repairs and replacements) (per million people)
- Coronary artery bypass graft surgery (CABG) (per million people)
- Hospitals with cardiac surgery (per million people)
- Hospitals with cardiac transplantation programmes (per million people)
- CVD incidence, Female
- CVD prevalence, Female
- CVD incidence, Both
- CVD prevalence, Both
- CVD incidence, Male
- IHD prevalence, Female
- IHD incidence, Both
- CVD prevalence, Male
- IHD prevalence, Both
- DALYs due to CVD, Male
- IHD incidence, Male
- DALYs due to CVD, Female
- IHD incidence, Female
- IHD prevalence, Male
- DALYs due to CVD, Both
- Stroke prevalence, Both
- DALYs due to IHD, Male
- DALYs due to stroke, Both
- Stroke incidence, Male
- DALYs due to IHD, Female
- Stroke prevalence, Male
- DALYs due to IHD, Both
- Stroke incidence, Female
- Stroke prevalence, Female
- Stroke incidence, Both
- DALYs due to stroke, Female
- DALYs due to peripheral arterial disease, Both
- Incidence of peripheral arterial disease, Male
- Incidence of peripheral arterial disease, Female
- Prevalence of peripheral arterial disease, Male
- Prevalence of peripheral arterial disease, Female
- Incidence of peripheral arterial disease, Both
- DALYs due to peripheral arterial disease, Female
- Prevalence of peripheral arterial disease, Both
- DALYs due to stroke, Male
- Incidence of atrial fibrillation, Female
- Prevalence of atrial fibrillation, Male
- Incidence of atrial fibrillation, Both
- Rheumatic heart disease incidence, Female
- Prevalence of atrial fibrillation, Female
- DALYs due to peripheral arterial disease, Male
- Rheumatic heart disease incidence, Both
- Prevalence of atrial fibrillation, Both
- DALYs due to atrial fibrillation, Both
- Incidence of atrial fibrillation, Male
- Rheumatic heart disease incidence, Male
- DALYs due to rheumatic heart disease, Both
- Rheumatic heart disease prevalence, Male
- DALYs due to rheumatic heart disease, Male
- Rheumatic heart disease prevalence, Female
- DALYs due to rheumatic heart disease, Female
- Rheumatic heart disease prevalence, Both
- DALYs due to air pollution, Female
- DALYs due to atrial fibrillation, Male
- DALYs due to air pollution, Male
- DALYs due to atrial fibrillation, Female
- DALYs due to air pollution, Both
- Premature deaths due to cardiovascular diseases, female (crude rate per 100000)
- Deaths due to cardiovascular diseases, male (crude rate per 100000)
- Deaths due to cardiovascular diseases, male (per 100000, age-standardized)
- Deaths due to cardiovascular diseases, female (per 100000, age-standardized)
- Deaths due to cardiovascular diseases, female (crude rate per 100000)
- Left, right and both ventricular assist device implantations (per million people)
- Cardiac resynchronization therapy device (CRT-D and CRT-P) implantations (per million people)
- Cardiac MRI units (per million people)
- Hospitals implanting left ventricular assist devices (LVAD) (per million people)
- Hospitals implanting Mitraclip (per million people)
- Hospitals with advanced ultrasound imaging (per million people)
- Cardiology departments performing device-based decongestion therapy (per million people)
- Palliative care units for patients with advanced/end-stage HF (per million people)
- Hospitals with cath labs and on-site cardiac surgery (per million people)
- Total cath labs (per million people)
- Percent of percutaneous coronary interventions (PCI) performed by trans-radial access
- Percutaneous tricuspid valve interventions (per million people)
- Percutaneous coronary interventions (PCI) for in-stent restenosis (per million people)
- Percutaneous coronary interventions (PCI) in unprotected left main (LM) coronary artery (per million people)
- Percutaneous coronary interventions (PCI) in coronary artery with chronic total occlusions (CTO) (per million people)
- Coronary bio-resorbable vascular scaffolds (per million people)
- Percutaneous coronary interventions (PCI) performed with adjunctive intracoronary physiology measurements (per million people)
- Adjunctive intracoronary physiology measurements (per million people)
- Percutaneous coronary interventions (PCI) performed with adjunctive intracoronary imaging techniques (per million people)
- Percutaneous coronary interventions (PCI) with rotational or orbital atherectomy (per million people)
- Adjunctive intracoronary imaging techniques (per million people)
- Percutaneous coronary interventions (PCI) with drug-eluting balloons (per million people)
- Atrial septum closures (per million people)
- Mitral balloon valvuloplasties (per million people)
- Procedures with cerebral embolic protection devices (per million people)
- Alcohol septum ablations (per million people)
- Valve-in-valve percutaneous implantations (per million people)
- Use of hemodynamic support devices (per million people)
- Ventricular septum closures (per million people)
- Peri-valvular leaks closures (per million people)
- Domestic private health expenditure (% of current health expenditure)
- GDP per capita, PPP (international $)
- Current health expenditure (% of GDP)
- GNI per capita, Atlas method (current US$)
- Current health expenditure per capita, PPP (current international $)
- Fertility rate, total (births per woman)
- Total population
- Life expectancy at birth, total (years)
- Unemployment, female (% of female labor force) (modeled ILO estimate)
- Life expectancy at birth, male (years)
- Life expectancy at birth, female (years)
- Mortality rate, infant (per 1,000 live births)
- Annual population growth rate (%)
- Urban population (% of total population)
- Unemployment, total (% of total labor force) (modeled ILO estimate)
- Age dependency ratio, old (% of working-age population)
- Gini index (World Bank estimate)
- Hospital beds (per 1,000 people)
- Median age by country. UN estimates
- Population ages 65 and above (% of total population)
- Physicians (per 1,000 people)
- Obesity (BMI >= 30), both (% population aged 18+, age-standardized)
- Obesity (BMI >= 30), male (% population aged 18+, age-standardized)
- Raised blood pressure, female (% population aged 18+, age-standardized)
- Obesity (BMI >= 30), female (% population aged 18+, age-standardized)
- Raised blood pressure, both (% population aged 18+, age-standardized)
- Mean systolic blood pressure (age-standardized estimate) 18+ years (female)
- Mean non-HDL cholesterol (mmol/L) (female)
- Mean total cholesterol (mmol/L) (male)
- Mean HDL cholesterol (mmol/L) (male)
- Raised blood pressure, male (% population aged 18+, age-standardized)
- Mean total cholesterol (mmol/L) (female)
- Mean HDL cholesterol (mmol/L) (female)
- Mean non-HDL cholesterol (mmol/L) (male)
- Mean systolic blood pressure (age-standardized estimate) 18+ years (male)
- Average Seasonal Population-Weighted Ozone, (ppb)
- Average Annual Population-Weighted PM2.5, (ug/m3)
- Daily smoking, female (% population aged 15+, age-standardized)
- Heavy episodic drinking (last 30 days), male (% population aged 15+, age-standardized)
- Heavy episodic drinking (last 30 days), female (% population aged 15+, age-standardized)
- Daily smoking, both (% population aged 15+, age-standardized)
- Daily smoking, male (% population aged 15+, age-standardized)
- Heavy episodic drinking (last 30 days), both (% population aged 15+, age-standardized)
- Estimated intake of sugar-sweetened beverages in adults aged 25 and older (g/day)
- Alcohol, total per capita (15+) consumption (in litres of pure alcohol) (female)
- Prevalence of insufficient physical activity among adults aged 18+ years (age-standardized estimate) (%) 2016 (total)
- Estimated intake of vegetables in adults aged 25 and older (g/day)
- Alcohol, total per capita (15+) consumption (in litres of pure alcohol) (total)
- Prevalence of insufficient physical activity among adults aged 18+ years (age-standardized estimate) (%) 2016 (male)
- Estimated intake of fruit in adults aged 25 and older (g/day)
- Estimated intake of sodium in adults aged 25 and older (g/day)
- Prevalence of insufficient physical activity among adults aged 18+ years (age-standardized estimate) (%) 2016 (female)
- Alcohol, total per capita (15+) consumption (in litres of pure alcohol) (male)
- Hospitals with cath labs performing TAVI (per million people)
- Coronary drug-eluting stents (per million people)
- Percutaneous coronary interventions (PCI) without stent (per million people)
- Left atrial appendage occlusions (per million people)
- Coronary stents (per million people)
- Aortic balloon valvuloplasties (per million people)
- Hospitals with dedicated stroke units (per million people)
- Hospitals with cardiac rehabilitation programmes (per million people)
- Hospitals with dedicated coronary care units (per million people)
- Hospital with cath labs (per million people)
- Hospitals with cath labs performing structural heart disease interventions in children (per million people)
- Hospitals with cath labs performing structural heart disease interventions in the adult (per million people)
- Hospitals with cath labs on 24 hours/7 days service (per million people)
- Hospitals implanting cardioverter defibrillators (ICDs) (per million people)
- Hospitals implanting pacemakers (per million people)
- Implantable cardioverter defibrillator (ICD) implantations (per million people)
- Hospitals undertaking electrophysiology procedures (per million people)
- Pacemaker implantations (per million people)
- Ablations to correct heart rhythm disorders (per million people)
- Hospitals implanting cardiac resynchronization therapy (CRT) devices (per million people)
- Coronary angiography and diagnostic cardiac catheterization (per million people)
- Percutaneous procedures for congenital heart disease (per million people)
- Hospitals undertaking congenital heart disease surgery (per million people)
- Cardiologists (total) (per million people)
- Interventional cardiologists (per million people)
- Cardiologists, females (% of cardiologists, total)
- Surgical interventions in congenital heart disease (per million people)
- Primary percutaneous coronary intervention (pPCI) (per million people)
- Percutaneous coronary interventions (PCI) (per million people)
- Percutaneous mitral valve interventions (per million people)
- Average length of stay in hospital primarily due to HF
- Number of HF-related hospital discharges (per million people)
- Hospitals performing HF exercise programs for HF patients (per million people)
- Hospitals with availability to obtain BNP (NT-proBNP) in ER (per million people)
- Hospitals performing spiro-ergometry (per million people)
- Hospitals with dedicated HF centers (per million people)
- Unemployment, male (% of male labor force) (modeled ILO estimate)
- Premature deaths due to cardiovascular diseases, male (crude rate per 100000)
- Cardiac surgeons (per million people)
- Heart transplantations (per million people)
- Degenerative mitral valve disease incidence, Both
- Calcific aortic valve disease prevalence, Male
- Calcific aortic valve disease incidence, Male
- DALYs due to degenerative mitral valve disease, Male
- DALYs due to calcific aortic valve disease, Both
- Calcific aortic valve disease incidence, Both
- Transfemoral transcatheter aortic valve implantations (per million people)
- Total interventional cardiologists (females) (% of interventional cardiologists, total)
- Interventional cardiologists performing transcatheter valvular heart disease interventions (per million people)
- Hospitals performing TAVI without on-site cardiac surgery (per million people)
- Total number of hybrid catheterisation rooms (per million people)
- Public hospitals with cardiac cath labs (per million people)
- Acute ischemic stroke interventions (per million people)
- Non-femoral transcatheter aortic valve implantations (per million people)
- Percutaneous coronary interventions (PCI) with bio-resorbable vascular scaffolds (per million people)
- Percutaneous coronary interventions (PCI) with coronary stents (per million people)
- Percutaneous coronary interventions (PCI) with drug-eluting coronary stents (per million people)
- Percutaneous coronary interventions (PCI) with intravascular lithotripsy (IVL) (per million people)
- TAVI for pure aortic regurgitation (per million people)
- TAVI performed in native aortic valve (excluding valve in valve) (per million people)
- Transapical transcatheter aortic valve implantations (per million people)
- Transcatheter aortic valve-in-valve implantations in previous TAVIs (per million people)
- Transcatheter aortic valve-in-valve implantations in surgical valve (per million people)
- Transcatheter interventions for congenital heart disease in adults (per million people)
- Transcatheter mitral valve in valve implantation with TAVI device (per million people)
- Transcatheter native mitral valve repairs (per million people)
- Transcatheter native mitral valve replacement (per million people)
- Transcatheter tricuspid valve repairs (per million people)
- Interventional cardiology operators in training (from your own country) (per million people)
- Transcatheter tricuspid valve replacement (per million people)
- Transvascular transcatheter aortic valve implantations (per million people)
- Percutaneous aortic valve implantation (TAVI) (per million people)
- Atrial fibrillation and/or atrial flutter ablations in female patients (% of all ablations)
- Implantable cardioverter defibrillator (ICD) implantations in female patients (% of all ICD implantations)
- Pacemaker implantations in female patients (% of all pacemaker implantations)
- Impella devices for heart failure (per million people)
- Intervention for acute pulmonary embolism (per million people)
- Percutaneous coronary interventions (PCI) in female patients (% of all PCI)
- Primary percutaneous coronary intervention (pPCI) in female patients (% of all pPCI)
- Transcatheter aortic valve implantation (TAVI) in female patients (% of all TAVI)
- Transcatheter mitral valve interventions in female patients (% of all mitral interventions)
- Coronary artery bypass graft surgery (CABG) in female patients (% of all CABG)
- ECMO for heart failure (per million people)
- Surgical aortic valve procedures (repairs and replacements) in female patients (% of all procedures)
- Left ventricular assist device implantations for acute and/or chronic heart failure (per million people)
- Surgical mitral valve procedures (repairs and replacements) (per million people)
- Surgical tricuspid valve procedures (repairs and replacements) (per million people)
- Prevalence of heart failure impairment due to CVD, Both
- Prevalence of heart failure impairment due to CVD, Female
- Prevalence of heart failure impairment due to CVD, Male
- YLDs of heart failure impairment due to CVD, Both
- YLDs of heart failure impairment due to CVD, Female
- YLDs of heart failure impairment due to CVD, Male
- Total cardiac surgeons (females) (% of cardiac surgeons, total)
- Ablations of atrial focal tachycardia, AV nodal tachycardias and ablations of atrio-ventricular bypass tract tachycardia (per million people)
- Ablations of ventricular tachycardia (per million people)
- Intervention for chronic pulmonary hypertension (per million people)
- Calcific aortic valve disease prevalence, Both
- DALYs due to degenerative mitral valve disease, Female
- DALYs due to degenerative mitral valve disease, Both
- Calcific aortic valve disease prevalence, Female
- DALYs due to calcific aortic valve disease, Female
- Degenerative mitral valve disease incidence, Male
- Degenerative mitral valve disease prevalence, Both
- Degenerative mitral valve disease prevalence, Female
- Degenerative mitral valve disease incidence, Female
- DALYs due to calcific aortic valve disease, Male
- Degenerative mitral valve disease prevalence, Male
- Calcific aortic valve disease incidence, Female